The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Polymer conjugates: nanosized medicines for treating cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Self-citationDe Duve, C., De Barsy, T., Poole, B., Trouet, A., Tulkens, P., & Van Hoof, F. (1974) · Biochemical Pharmacology · doi:10.1016/0006-2952(74)90174-9 · Cited by 1,901
Bolla, M., Collette, L., Blank, L., Warde, P., Dubois, J. B., Mirimanoff, R.-O., Storme, G., Bernier, J., Kuten, A., Sternberg, C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09408-4 · Cited by 1,686
Ligand-targeted therapeutics in anticancer therapy
Allen, T. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc903 · Cited by 1,647
Biological Responses to Materials
Anderson, J. M. (2001) · Annual Review of Materials Research · doi:10.1146/annurev.matsci.31.1.81 · Cited by 1,465
Structure and properties of pharmacologically active polymers
Ringsdorf, H. (1975) · Journal of Polymer Science: Polymer Symposia · doi:10.1002/polc.5070510111 · Cited by 1,094
Vasey, P. A., Kaye, S. B., Morrison, R. A., Twelves, C. J., Wilson, P., Duncan, R., Thomson, A. H., Murray, L. S., Hilditch, T. E., Murray, T., et al. (1999) · PubMed · Cited by 689
Self-citationSMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy
Maeda, H. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00134-4 · Cited by 662
Maeda, H., Fang, J., Inutsuka, T., & Kitamoto, Y. (2003) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00271-0 · Cited by 537
Metastasis suppressors alter the signal transduction of cancer cells
Steeg, P. S. (2003) · Nature Reviews Cancer · doi:10.1038/nrc967 · Cited by 502
Polymeric anticancer drugs with pH-controlled activation
Ulbrich, K. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.040 · Cited by 494
Hepatic Drug Targeting: Phase I Evaluation of Polymer-Bound Doxorubicin
Seymour, L. W., Ferry, D. R., Anderson, D., Hesslewood, S., Julyan, P. J., Poyner, R., Doran, J., Young, A., Burtles, S. S., & Kerr, D. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1668 · Cited by 435
Dendrimer-platinate: a novel approach to cancer chemotherapy.
Malik, N., Evagorou, E. G., & Duncan, R. (1999) · PubMed · Cited by 417
Self-citationDendrimer-platinate: a novel approach to cancer chemotherapy
Malik, N., Evagorou, E. G., & Duncan, R. (1999) · Anti-Cancer Drugs · doi:10.1097/00001813-199909000-00010 · Cited by 402
Self-citationTherapeutic antibody fragments with prolonged in vivo half-lives
Chapman, A. P., Antoniw, P., Spitali, M., West, S., Stephens, S., & King, D. J. (1999) · Nature Biotechnology · doi:10.1038/11717 · Cited by 350
Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470
Satchi-Fainaro, R., Puder, M., Davies, J. W., Tran, H. T., Sampson, D. A., Greene, A. K., Corfas, G., & Folkman, J. (2004) · Nature Medicine · doi:10.1038/nm1002 · Cited by 345
Seymour, L. W., Miyamoto, Y., Maeda, H., Brereton, M., Strohalm, J., Ulbrich, K., & Duncan, R. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(94)00514-6 · Cited by 337
Self-citationHeil, G., Hoelzer, D., Sanz, M. A., Lechner, K., Liu Yin, J. A., Papa, G., Noens, L., Szer, J., Ganser, A., O'Brien, C., et al. (1997) · Blood · doi:10.1182/blood.v90.12.4710 · Cited by 332
Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation
Shaunak, S., Thomas, S., Gianasi, E., Godwin, A., Jones, E., Teo, I., Mireskandari, K., Luthert, P., Duncan, R., Patterson, S., et al. (2004) · Nature Biotechnology · doi:10.1038/nbt995 · Cited by 331
Self-citationPegaspargase: a review of clinical studies
Graham, M. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00110-8 · Cited by 322
Holmes, F. A., Jones, S. E., O’Shaughnessy, J., Vukelja, S., George, T., Savin, M., Richards, D., Glaspy, J., Meza, L., Cohen, G., et al. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf130 · Cited by 291
Meerum Terwogt, J. M., ten Bokkel Huinink, W. W., Schellens, J. H., Schot, M., Mandjes, I. A., Zurlo, M. G., Rocchetti, M., Rosing, H., Koopman, F. J., & Beijnen, J. H. (2001) · Anti-Cancer Drugs · doi:10.1097/00001813-200104000-00003 · Cited by 279
Davis, F. F. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00021-2 · Cited by 278
Introduction and overview of peptide and protein pegylation
(2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00020-0 · Cited by 235
Rademaker-Lakhai, J. M., Terret, C., Howell, S. B., Baud, C. M., de Boer, R. F., Pluim, D., Beijnen, J. H., Schellens, J. H. M., & Droz, J.-P. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0315 · Cited by 214
SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy
Maeda, H. (1991) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(91)90040-j · Cited by 213
Polymer Therapeutics Designed for a Combination Therapy of Hormone‐Dependent Cancer
Vicent, M. J., Greco, F., Nicholson, R. I., Paul, A., Griffiths, P. C., & Duncan, R. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200462960 · Cited by 199
Self-citationZalipsky, S., Qazen, M., Walker, J. A., Mullah, N., Quinn, Y. P., & Huang, S. K. (1999) · Bioconjugate Chemistry · doi:10.1021/bc990031n · Cited by 198
Enzymatic procedure for site-specific pegylation of proteins
Sato, H. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00024-8 · Cited by 187
Angiogenesis modulation in cancer research: novel clinical approaches
Cristofanilli, M., Charnsangavej, C., & Hortobagyi, G. N. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd819 · Cited by 179
Shukla, S., Wu, G., Chatterjee, M., Yang, W., Sekido, M., Diop, L. A., Müller, R., Sudimack, J. J., Lee, R. J., Barth, R. F., et al. (2003) · Bioconjugate Chemistry · doi:10.1021/bc025586o · Cited by 174
Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides
Dharap, S. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00209-8 · Cited by 172
Antibody-targeted chemotherapy with immunoconjugates of calicheamicin
Damle, N. K. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(03)00083-3 · Cited by 155
Recent Advances in Brain Tumor Therapy: Local Intracerebral Drug Delivery by Polymers
Guérin, C. J., Olivi, A., WEINGART, J. D., Lawson, H. C., & Brem, H. (2003) · Investigational New Drugs · doi:10.1023/b:drug.0000006172.65135.3e · Cited by 153
Kobayashi, H., Kawamoto, S., Sakai, Y., Choyke, P. L., Star, R. A., Brechbiel, M. W., Sato, N., Tagaya, Y., Morris, J. C., & Waldmann, T. A. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh124 · Cited by 151
Paclitaxel poliglumex (XYOTAX; CT-2103): an intracellularly targeted taxane
Singer, J. W., Shaffer, S. A., Baker, B., Bernareggi, A., Stromatt, S. C., Nienstedt, D., & Besman, M. (2005) · Anti-Cancer Drugs · doi:10.1097/00001813-200503000-00003 · Cited by 149
Cao, Y. (2004) · The biomedical & life sciences collection. · doi:10.1016/j.semcancer.2003.09.018 · Cited by 148
Protein, peptide and non-peptide drug PEGylation for therapeutic application
Pasut, G., Guiotto, A., & Veronese, F. (2004) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.14.6.859 · Cited by 145
PDEPT: polymer-directed enzyme prodrug therapy
Satchi, R., Connors, T. A., & Duncan, R. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2026 · Cited by 132
Self-citationAntibody-targeted Polymer–doxorubicin Conjugates with pH-controlled Activation
Ulbrich, K., Etrych, T., Chytil, P., Jelínková, M., & Řı́hová, B. (2004) · Journal of drug targeting · doi:10.1080/10611860400011869 · Cited by 128
Polymeric Drug Delivery Systems
Kim, S. W., Petersen, R. V., & Feijén, J. (1980) · Elsevier eBooks · doi:10.1016/b978-0-12-060310-7.50010-9 · Cited by 125
Epidermal growth factor receptor tyrosine kinase inhibitors
Ranson, M. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601873 · Cited by 118
Tomlinson, R. D., Klee, M., Garrett, S., Heller, J., Duncan, R., & Brocchini, S. (2001) · Macromolecules · doi:10.1021/ma0108867 · Cited by 118
Self-citationPegylated Interferon Alfa-2b Treatment for Patients With Solid Tumors: A Phase I/II Study
Bukowski, R. M., Ernstoff, M. S., Gore, M. E., Nemunaitis, J. J., Amato, R. J., Gupta, S. K., & Tendler, C. L. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.02.051 · Cited by 117
Pharmaceutical Excipient Development: The Need for Preclinical Guidance
Baldrick, P. (2000) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.2000.1421 · Cited by 112
The Synthesis and Testing of Anti-Cancer Therapeutic Nanodevices
Baker, J. R., Quintana, A., Piehler, L. T., Banazak-Holl, M., Tomalia, D. A., & Raczka, E. (2001) · Biomedical Microdevices · doi:10.1023/a:1011485622697 · Cited by 107
Shiah, J.-G., Sun, Y., Kopečková, P., Peterson, C. M., Straight, R. C., & Kopec̆ek, J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00325-x · Cited by 105
Polymeric Drug Delivery Systems
(2005) · CRC Press eBooks · doi:10.1201/9780849348129 · Cited by 98
Satchi‐Fainaro, R., Hailu, H., Davies, J. W., Summerford, C., & Duncan, R. (2003) · Bioconjugate Chemistry · doi:10.1021/bc020091k · Cited by 94
Self-citationOmelyanenko, V. G., Kopečková, P., Gentry, C. A., Shiah, J.-G., & Kopec̆ek, J. (1996) · Journal of drug targeting · doi:10.3109/10611869608996827 · Cited by 91
Signal Transduction–Directed Cancer Treatments
Sausville, E. A., Elsayed, Y. A., Monga, M., & Kim, G. (2003) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.135813 · Cited by 89
Signal Events: Cell Signal Transduction and Its Inhibition in Cancer
Rowinsky, E. K. (2003) · The Oncologist · doi:10.1634/theoncologist.8-suppl_3-5 · Cited by 86
Water-Soluble Degradable Hyperbranched Polyesters: Novel Candidates for Drug Delivery?
Gao, C., Xu, Y., Yan, D., & Chen, W. (2003) · Biomacromolecules · doi:10.1021/bm025738i · Cited by 82
Pharmacology of Escherichia coli-L-asparaginase polyethylene glycol adduct.
Park, Y. K., Abuchowski, A., Davis, S., et al. (1981) · PubMed · Cited by 72
IHOVA, B. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00235-9 · Cited by 69
Handbook of Anticancer Drug Development
Budman, D. R., Calvert, H., Rowinsky, E. K., & Hill, B. T. (2004) · Anti-Cancer Drugs · doi:10.1097/00001813-200411000-00011 · Cited by 55
Handbook of Anticancer Drug Development
Subramanian, B. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601984 · Cited by 48
N-(2-Hydroxypropyl)methacrylamide Copolymer Conjugates
Duncan, R. (2005) · CRC Press eBooks · doi:10.1201/9780849348129-4 · Cited by 44
Self-citationApoptosis: target for novel drugs
Alam, J. J. (2003) · Trends in biotechnology · doi:10.1016/j.tibtech.2003.08.006 · Cited by 40
Maeda, H., & Konno, T. (1997) · Springer eBooks · doi:10.1007/978-4-431-66914-2_12 · Cited by 35
Langer, C. J., Socinski, M. A., & O'Byrne, K. J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.lba7011 · Cited by 28
Phase I study of CT-2106 (polyglutamate camptothecin) in patients with advanced malignancies
Springett, G. M., Takimoto, C. H. M., McNamara, M., Doroshow, J. H., Syed, S. S., Eastham, E., Spriggs, D. R., Pezzulli, S., Michelson, G. C., & Dupont, J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.22.90140.3127 · Cited by 24
Targeting and Intracellular Delivery of Drugs
Duncan, R. (2006) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.200500014 · Cited by 23
Self-citationDelman, K. A., Brown, T. D., Thomas, M., Ensor, M., Holtsberg, F. W., Bomalaski, J. S., Clark, M. A., & Curley, S. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.4139 · Cited by 17
Cheng, P., Lo, T. W.-H., Leung, T.-W., Lam, A. T., & Lam, W.-M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.3179 · Cited by 9
Proteolysis of xyotax by lysosomal cathepsin B; metabolic profiling in tumor cells using LC-MS
(2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)81079-6 · Cited by 8
Omelyanenko, V. G., Kopečková, P., Gentry, C. A., Shiah, J.-G., & Kopec̆ek, J. (2003) · Journal of drug targeting · doi:10.1080/10611860310001636548 · Cited by 6
Cited by
Designing hydrogels for controlled drug delivery
Li, J., & Mooney, D. J. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.71 · Cited by 4,832
Exploiting the enhanced permeability and retention effect for tumor targeting
Iyer, A. K., Khaled, G., Fang, J., & Maeda, H. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.07.005 · Cited by 1,846
Applications of Orthogonal “Click” Chemistries in the Synthesis of Functional Soft Materials
Iha, R. K., Wooley, K. L., Nyström, A. M., Burke, D. J., Kade, M. J., & Hawker, C. J. (2009) · Chemical Reviews · doi:10.1021/cr900138t · Cited by 1,468
multifunctional enzymes in cancer
Mohamed, M. M., & Sloane, B. F. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1949 · Cited by 1,265
Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect
Maeda, H., Bharate, G. Y., & Daruwalla, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.11.010 · Cited by 1,168
Metadata
- Authors
- Vicent, M. J., & Duncan, R.
- Venue
- Trends in Biotechnology
- Publisher
- Elsevier BV
- Published
- 2006-01
- Volume
- 24
- Issue
- 1
- Pages
- 39-47
- ISSN
- 0167-7799 (ISSN-L)
- OpenAlex
- W2095016306
- Cited by
- 443
- References
- 69
- FWCI
- 2.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.